stock-detail (AGIO)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

Cancer Patients Miss Appointments, Prescriptions Due To Inability To Afford Care

6/6/2016 02:02 pm

(UNC Health Care) June 3, 2016 - More than one-in-four cancer patients had to pay more for medical care than they could afford, according to a study led by UNC Lineberger member Stacie Dusetzina, PhD. A reported 18 percent were unable to afford their prescription medications.

CancerCare® Releases Landmark Patient Access and Engagement Report

5/11/2016 11:03 am

(CancerCare) May 11, 2016 - A landmark report illustrating the many physical, emotional, financial, practical and informational needs cancer patients experience during and after clinical treatment was released today by CancerCare, a national nonprofit organization that provides free psychosocial support, education and financial assistance to anyone affected by cancer.

Bayer Joins Forces with Advocacy Organizations to Support Disease Education During Colon Cancer Awareness Month

3/1/2016 11:04 am

(Bayer) Mar 1, 2016 - To mark Colorectal Cancer Awareness Month, Bayer unites with patient advocacy organizations Colon Cancer Alliance and Fight Colorectal Cancer to raise greater awareness about the disease and its progression.

Waste in Cancer Drugs Costs $3 Billion a Year, a Study Says

3/1/2016 06:05 am

(New York Times) Mar 1, 2016 - Many drug makers exclusively sell one-size-fits-all vials, meaning patients pay thousands for medicine they are never given, researchers say.

Sparing Ovaries and Removing Fallopian Tubes May Cut Cancer Risk, But Few Have Procedure

1/21/2016 11:05 am

(Yale News) Jan 21, 2016 - During hysterectomies for non-cancerous conditions, removing both fallopian tubes while keeping the ovaries may help protect against ovarian cancer while preserving hormonal levels, but few women receive this surgical option, according to a new study by Yale School of Medicine researchers.

To Discover Better Drugs Faster, MD Anderson Is Innovating How It Innovates

1/5/2016 12:04 pm

(Forbes) Jan 4, 2016 - At MD Anderson they’re working on a new, more integrated model they hope will revolutionize the pharmaceutical industry and early signs suggest that it’s working.

Merck’s Erbitux Approved For NHS Wales

1/5/2016 12:04 pm

(Pharmafile [UK]) Jan 5, 2016 - The All Wales Medicines Strategy Group has recommended Merck’s Erbitux in combination with chemotherapy for restricted use in the NHS in Wales.

Opinion: Oncology’s Future: Liquid Biopsies and the Heterogeneity of Cancer

1/5/2016 12:04 pm

(Xconomy San Diego) Jan 5, 2016 - The root of the problem is not oncologists, but rather the diagnostics tools available to them.

Dr. Paul Janssen Award for Biomedical Research Issues 2016 Call for Nominations

1/5/2016 12:04 pm

( Jan 5, 2016 - The Dr. Paul Janssen Award for Biomedical Research today opens its 2016 call for nominations. This prestigious award recognizes individuals whose basic or clinical discoveries have made, or have the potential to make, significant contributions toward improving human health.

Nanobiotix Starts A New Research Program, In Immuno Oncology, With Its Lead Product NBTXR3

1/5/2016 12:03 pm

(Nanobiotix) Jan 5, 2016 - Nanobiotix, a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces today that, in addition to its current advanced clinical development program, the Company has started exploring the use of NBTXR3 for combination in Immuno Oncology.

Risk of Heart Damage Follows Some Childhood Cancer Survivors

1/5/2016 12:02 pm

(Reuters Health) Jan 4, 2016 - Childhood cancer survivors may face an increased risk of heart damage after exposure to certain chemotherapy and radiation treatments, a U.S. analysis suggests.

Novel RNA Delivery System May Treat Incurable Blood Cancers

1/5/2016 12:02 pm

(TAU) Jan 5, 2016 - TAU researchers develop unique system to deliver therapy at site of Mantle Cell Lymphoma.

Oncodesign Biotechnology and Bristol-Myers Squibb Enter into Strategic Drug Discovery Collaboration

1/5/2016 12:02 pm

(Yahoo! Finance) Jan 5, 2016 - Oncodesign today announced that it has entered into a strategic collaboration agreement with Bristol-Myers Squibb Company to discover, develop and commercialize novel macrocyclic compounds.

Circulating Tumor Cells Linked With Treatment Resistance And Response In Prostate Cancer Patients

1/5/2016 12:01 pm

(Epic Sciences) Jan 4, 2016 - Research teams at Memorial Sloan Kettering Cancer Center and Epic Sciences have found that greater diversity among circulating tumor cells (CTCs) in the blood of advanced prostate cancer patients predicts not only shorter overall survival, but also the development of resistance to key anti-androgen therapies.

Twin Study Estimates Familial Risks Of 23 Different Cancers

1/5/2016 12:01 pm

(Harvard T.H. Chan School of Public Health) Jan 5, 2016 - A large new study of twins has found that having a twin sibling diagnosed with cancer poses an excess risk for the other twin to develop any form of cancer.

Triple Lung Cancer Therapy With Experimental Drugs And Radiation Targets Most Resistant Cancers

1/5/2016 12:01 pm

(Thomas Jefferson/Sidney Kimmel Cancer Center blog) Jan 4, 2016 - One new study out of Thomas Jefferson University in Philadelphia has been experimenting with a triple therapy that has proved effective for KRAS gene mutations in mice. The triple therapy involves two experimental drugs in combination with radiation therapy.

Improving Access To Clinical Trials When Biopsies Are Required

1/5/2016 12:01 pm

(IASLC) Jan 4, 2016 - The requirement for tumor tissue specimens and associated analyses in order to participate in clinical trials appears to be a significant barrier to clinical trial enrollment and may delay treatment.

New Paste Prevents Scarring Caused by Radiation Therapy for Cancer

1/5/2016 12:01 pm

(NYU Langone) Jan 4, 2016 - An antiscarring paste when applied to the skin of mice halts fibrosis caused by the radiation used in cancer therapy.

Which Kidney Cancer Drug on Progression? Surprising Answers

1/5/2016 11:05 am

(Medscape Medical News) Jan 5, 2016 - Phase 3 data presented on the oral agent cabozantinib (Cometriq, Exelixis) during a presscast held in advance of the Genitourinary Cancers Symposium 2016 reaffirm that it provides an unprecedented benefit in slowing the progression of advanced kidney cancer in the second-line setting.

Regular Use of Aspirin May Lower Men’s Risk of Advanced Prostate Cancer

1/5/2016 11:04 am

(Wall Street Journal) Jan 4, 2016 - Researchers reported that men who took at least three aspirins a week reduced their risk of developing or dying from advanced prostate cancer.

ASCO’s Quality Training Program Leads to Improvement Learning in Oncology

8/19/2015 11:04 am

(ASCO in Action) Aug 18, 2015 - A new article published in the Journal of Oncology Practice studies how structured training programs improve health professionals’ skills in performing clinical care and research.

GE Healthcare First to Receive FDA Clearance for Low Dose CT Lung Cancer Screening

8/17/2015 11:03 am

(GE Healthcare) Aug 17, 2015 - GE Healthcare is proud to be the first company with a low dose computed tomography (CT) lung cancer screening option that is cleared by the U.S. FDA for lung cancer screening.

Advance in Photodynamic Therapy Offers New Approach to Ovarian Cancer

8/14/2015 10:05 am

(OSU) Aug 13, 2015 - Researchers at Oregon State University have made a significant advance in the use of photodynamic therapy to combat ovarian cancer in laboratory animals, using a combination of techniques that achieved complete cancer cell elimination with no regrowth of tumors.

Pancreatic Cancer Action Network's Enhanced Patient Services and Clinical Initiatives to Transform the Fight Against Pancreatic Cancer

6/9/2015 12:02 pm

(NEWS.GNOM.ES) June 9, 2015 - The Clinical Trial Finder is the latest initiative that the Pancreatic Cancer Action Network is bringing to market for the pancreatic cancer community as part of its increased efforts to double survival of pancreatic cancer.

Stada Agrees Oncology Deal With Indian Hetero Drugs

3/26/2015 12:03 pm

(Reuters) Mar 26, 2015 - German generic drugmaker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday.